Company: LRHC
Filing Date: 2025-11-19
Form Type: 10-Q
Source: 0001213900-25-112656
Chunk: 288

Company: La Rosa Holdings Corp.
Filing Date: 2025-11-19
Form: 10-Q
Item: Item 2
Chunk 288
---
 the number of authorized shares of our common stock to ensure that the Company has a sufficient number of authorized shares
reserved for issuance to equal at least 200% of the maximum number of shares issuable upon conversion of the Notes, as determined under
the Securities Purchase Agreement. Such approval was effective on March 27, 2025, or 20 days after commencement of mailing of the definitive
information statement regarding this approval to the stockholders of the Company.

On June 18, 2025, with the prior approval by
the Company’s Board of Directors, the Company and the 2025 Investor entered into, and closed the transactions contemplated by,
that certain Amendment and Exchange Agreement (the “Exchange Agreement”) pursuant to which (among other things) the 2025
Investor surrendered and exchanged all of its Incremental Warrants in exchange for (the “Exchange”) 6,000 shares of the Company’s
Series B Convertible Preferred Stock, par value $0.0001 per share (“Series B Preferred Stock”). On the same date, the Company
filed a Certificate of Designation of Rights and Preferences of the Series B Preferred Stock (the “Certificate of Designation”)
with the Secretary of State of the State of Nevada. The Initial Note remains outstanding post-Exchange. 

Pursuant
to the terms of the Exchange Agreement, conversion of the Series B Preferred Stock into shares of common stock of the Company in excess
of 19.99% of the Company’s outstanding shares of common stock is conditional upon obtaining the approval of the Company’s
stockholders in accordance with the rules and regulations of the Nasdaq Capital Market. On July 9, 2025, Joseph La Rosa and JLR-JCCLT1
Land Trust, controlled by Mr. La Rosa, approved such conversion and the terms of the Exchange Agreement in their capacity as stockholders
of the Company holding a majority of the voting power of the Company by written consent in lieu of having a stockholders meeting. On
July 11, 2025, the Company filed a preliminary information statement on Schedule 14C with the SEC notifying stockholders of such written
consent. On July 21, 2025, the Company filed a definitive information statement on Schedule 14C with the SEC and commenced mailing the
definitive information statement to stockholders of record as of the close of business on July 9, 2025. Such stockholders’ approval
became effective on August